Neurological complications of infliximab.
Roos
Jonathan C P
JC
Ostor
Andrew J K
AJ
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003711:Demyelinating Diseases / Q000175:diagnosis / Q000209:etiology / Q000473:pathology; D003937:Diagnosis, Differential; D006801:Humans; D000069285:Infliximab; D007577:JC Virus / Q000472:pathogenicity; D007968:Leukoencephalopathy, Progressive Multifocal / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology; D008279:Magnetic Resonance Imaging; D016133:Polymerase Chain Reaction; D027601:Polyomavirus Infections / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000209:etiology*; D012216:Rheumatic Diseases / Q000188:drug therapy; D012680:Sensitivity and Specificity; D014412:Tumor Virus Infections / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000209:etiology*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab